Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Brightpoint Inc. (CELL) declared solid financial results for the fourth quarter of 2011, beating the Zacks Consensus Estimates. However, management reduced its prior financial outlook for fiscal 2012 due to stronger than normal seasonality in the ensuing first quarter and a broader global macro-economic volatility.
Quarterly total revenue was $1,556.4 million, an improvement of 39% year over year and 16% sequentially. This was also significantly above the Zacks Consensus Estimate of $1,410 million. In the fourth quarter of 2011, the company managed 30.710 million wireless devises (including 0.8 million tablets), up 6% year over year and 13% sequentially.
This was a quarterly record for Brightpoint. This fabulous performance was primarily attributable to a massive growth in Distribution business, backed by increasing demand for smartphones and tablets, which have higher average selling prices and an improvement in supply-chain management system.
Quarterly GAAP net income from continuing operations was $15.1 million or 22 cents per share compared with a net income of $15.9 million or 22 cents per share in the prior-year quarter. However, adjusted (excluding special items) EPS in the reported quarter was 31 cents, beating the Zacks Consensus Estimate of 30 cents.
Segment wise, Distribution revenue was $1,415.8 million in the fourth quarter of 2011 compared with $1,022.1 million in the year-ago quarter. Logistics Services revenue was $140.6 million compared with $98.2 million in the prior-year quarter.
In the reported quarter, on a GAAP basis, gross margin was 6.5% compared with 8.5% in the prior-year quarter. SG&A expenses were $70 million compared with $62.3 million in the year-ago quarter. QuarterlyEBITDA came in at $34.9 million compared with $30.6 million in the year-ago quarter.
During fiscal 2011, Brightpoint used approximately $81 million of cash for operations compared with a cash generation of $160.4 million in the year-ago period. Free cash flow (cash flow from operation less capital expenditure) in fiscal 2011 was a negative $141.3 million compared with $118.3 million in fiscal 2010.
At the end of fiscal 2011, Brightpoint had $40.8 million of cash & marketable securities on its balance sheet compared with $41.7 million at the end of 2010. Total debt was $253 million at the end of fiscal 2011 compared with $90.4 million at the end of 2010. Debt-to-capitalization ratio, at the end of fiscal 2011, was 0.46 compared with 0.29 at the end of 2010.
Future Financial Outlook
Management reduced its previous guidance for fiscal 2012. The new GAAP EPS will be within the range of 66 cents to 76 cents compared with 67 cents to 79 cents estimated earlier. The updated non-GAAP EPS will be within the range of $1.07 to $1.17 compared with $1.08 to $1.20 estimated earlier. For fiscal 2012, estimated distribution gross margin is within the range of 3.6% to 4.0% and logistic services gross margin came in at 35% and 40%.
Recommendation
We believe the long-term business prospect of Brightpoint remains intriguing buoyed by the growing demand for high-end pocket digital assistances globally.In our view, the termination of the proposed merger between AT&T Inc. (T - Analyst Report) and T-Mobile USA is a major relief for Brightpoint as this deal had the potential to push the company’s high-margin logistic businesses in danger. We thus maintain our long-term Outperform recommendation on Brightpoint. Currently, it holds a short-term Zacks #3 (Hold) Rank on the stock.
Get the full Analyst Report on T - FREE